Strategic Partnership
MCA & GST VerifiedHigh ROI Opportunity
Project US-109

US-FDA & WHO-GMP Certified Solid Oral Formulation Plant in Jaipur

22% EBITDA Margins • ₹49.13 Cr ARR • Turnkey Operation

Healthcare & PharmaJaipur, RajasthanEst. 2014 (12 yrs)87 Full-Time Employees27 views today
US-FDA & WHO-GMP Certified Solid Oral Formulation Plant in Jaipur
93% AI Match ScoreStrong Deal Health
Asking Valuation
₹36.75 Cr3.4x EBITDA
Annual Revenue₹49.13 Cr
EBITDA₹10.81 Cr
EBITDA Margin22%
Net Profit₹7.78 Cr
Seller Representation:Verified Founder / Promoter
Advisor Response Rate:Under 2 Hours
Audited Documents:23 Confidential Files

Executive Summary

Highly profitable and established Healthcare & Pharma enterprise operating out of Jaipur, Rajasthan. Established in 2014, the company has built a pristine client base, deep operating moats, and verified audited books.

Key Investment Highlights & Competitive Moats

Audited FY25-26 revenue of ₹49.13 Cr with verified 22% EBITDA margins
Pristine compliance history with clean GST, MCA, and Income Tax records
48000 sq.ft (Long-Term Leased) modern facility fully equipped with compliant infrastructure
Experienced senior management team remaining post-acquisition for seamless transition

Identified Growth Corridors & Upside Potential

Expansion into Tier-1 export corridors and digital marketplace channels
Capacity utilization currently at 65%, offering immediate upside with existing fixed assets
Strategic synergies for synergistic corporate acquirers and PE roll-up platforms

Hard Assets, Real Estate & IP Included in Sale

  • All plant machinery, tools, and compliant operating equipment
  • Brand trademarks, proprietary customer contracts, and supplier databases
  • Working capital transition support and transfer of operating licenses

Reason for Divestment / Capital Raise

Seeking strategic institutional partner for pan-India expansion

Similar Verified Opportunities

Curated deals matching similar industry and EBITDA parameters.

Explore All Deals
Diagnostic Lab Chain & Pathology Network across 14 Centers in Indore
Hot DealAsset Sale
94% AI MatchGood Health
DD CertifiedHigh ROI
Revenue₹53.02 Cr
EBITDA₹12.19 Cr
EBITDA Margin23%
Multiple3.8x EBITDA
11 yrs • 95 team28 views today
Asking Price₹46.34 Cr
Listed 12d ago
Details
NABH-Accredited 75-Bed Multi-Specialty Surgical Hospital in Coimbatore
Hot DealFull Buyout
95% AI MatchExcellent Health
DD CertifiedHigh ROI
Revenue₹59.03 Cr
EBITDA₹14.17 Cr
EBITDA Margin24%
Multiple4.2x EBITDA
10 yrs • 103 team29 views today
Asking Price₹59.50 Cr
Listed 13d ago
Details
API & Intermediates Chemical Synthesis Manufacturing Unit in Chandigarh
Hot DealPartial Equity
96% AI MatchStrong Health
KYC VerifiedHigh ROI
Revenue₹63.44 Cr
EBITDA₹15.86 Cr
EBITDA Margin25%
Multiple2.2x EBITDA
9 yrs • 111 team30 views today
Asking Price₹34.89 Cr
Listed 14d ago
Details